Fuso Pharmaceutical Industries,Ltd. (4538.T)
JPY 2585.0
(0.35%)
JPY 2585.0
(0.35%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 55.4 Billion | 51.01 Billion | 49.63 Billion | 49.25 Billion | 46.9 Billion | 46.07 Billion |
| Cost of Revenue | 41.88 Billion | 37.27 Billion | 36.23 Billion | 35.14 Billion | 34.1 Billion | 32.64 Billion |
| Gross Profit | 13.51 Billion | 13.74 Billion | 13.39 Billion | 14.11 Billion | 12.8 Billion | 13.42 Billion |
| Operating Expenses | 11.55 Billion | 11.53 Billion | 11.47 Billion | 11.76 Billion | 11.79 Billion | 12.16 Billion |
| Selling, General and Administrative Expenses | 10.08 Billion | 9.8 Billion | 9.54 Billion | 9.81 Billion | 9.87 Billion | 9.9 Billion |
| Research and Development Expenses | 1.46 Billion | 1.35 Billion | 1.44 Billion | 1.46 Billion | 1.4 Billion | 1.76 Billion |
| Other Expenses | - | -36 Million | 47 Million | 4 Million | 121 Million | 126 Million |
| Cost and Expenses | 53.44 Billion | 48.8 Billion | 47.7 Billion | 46.9 Billion | 45.89 Billion | 44.81 Billion |
| Operating Income | 1.96 Billion | 2.2 Billion | 1.92 Billion | 2.35 Billion | 1.01 Billion | 1.26 Billion |
| Interest Expense | 171 Million | 165 Million | 176 Million | 196 Million | 224 Million | 226 Million |
| Income Tax Expense | 389 Million | 599 Million | 427 Million | 737 Million | 335 Million | 361 Million |
| Earnings before Tax | 1.76 Billion | 2.2 Billion | 1.91 Billion | 2.34 Billion | 1.04 Billion | 1.25 Billion |
| Net Income | 1.37 Billion | 1.6 Billion | 1.48 Billion | 1.6 Billion | 707 Million | 894 Million |
| Earnings Per Share Basic | 159.92 | 182.99 | 169.05 | 183.16 | 80.57 | 101.86 |
| Earnings Per Share Diluted | 159.92 | 182.99 | 169.05 | 183.16 | 80.57 | 101.86 |
| Weighted Average Shares Outstanding | 8.61 Million | 8.77 Million | 8.77 Million | 8.77 Million | 8.77 Million | 8.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.61 Million | 8.77 Million | 8.77 Million | 8.77 Million | 8.77 Million | 8.77 Million |
| Gross Margin | 0.24 | 0.27 | 0.27 | 0.29 | 0.27 | 0.29 |
| EBIT Margin | 0.07 | 0.09 | 0.09 | 0.10 | 0.08 | 0.07 |
| Profit Margin | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 |
| EBITDA | 3.67 Billion | 4.63 Billion | 4.46 Billion | 4.79 Billion | 3.45 Billion | 3.44 Billion |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.04 | 0.05 | 0.02 | 0.03 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 14.62 Billion | 12.57 Billion | 55.4 Billion | 15.4 Billion | 13.91 Billion | 13.5 Billion |
| Cost of Revenue | 10.44 Billion | 9.44 Billion | 41.88 Billion | 11.57 Billion | 10.54 Billion | 10 Billion |
| Gross Profit | 4.17 Billion | 3.13 Billion | 13.51 Billion | 3.83 Billion | 3.37 Billion | 3.5 Billion |
| Operating Expenses | 3.02 Billion | 3 Billion | 11.55 Billion | 3.08 Billion | 2.86 Billion | 2.91 Billion |
| Selling, General and Administrative Expenses | 3.02 Billion | 2.59 Billion | - | 2.67 Billion | 2.55 Billion | 2.58 Billion |
| Research and Development Expenses | - | 419 Million | - | 413 Million | 309 Million | 328 Million |
| Other Expenses | - | -17 Million | -1 Million | 17 Million | -10 Million | 9 Million |
| Cost and Expenses | 13.47 Billion | 12.45 Billion | 53.44 Billion | 14.66 Billion | 13.4 Billion | 12.91 Billion |
| Operating Income | 1.15 Billion | 122 Million | 1.96 Billion | 743 Million | 510 Million | 589 Million |
| Interest Expense | 38 Million | 44 Million | 171 Million | 46 Million | 43 Million | 38 Million |
| Income Tax Expense | 269 Million | -121 Million | 389 Million | 202 Million | 96 Million | 212 Million |
| Earnings before Tax | 901 Million | 29 Million | 1.76 Billion | 713 Million | 333 Million | 692 Million |
| Net Income | 632 Million | 150 Million | 1.37 Billion | 510 Million | 238 Million | 479 Million |
| Earnings Per Share Basic | 73.97 | 17.72 | - | 60.27 | 27.29 | 54.62 |
| Earnings Per Share Diluted | 73.97 | 17.72 | - | 60.27 | 27.29 | 54.62 |
| Weighted Average Shares Outstanding | 8.54 Million | 8.46 Million | 8.61 Million | 8.46 Million | 8.72 Million | 8.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 8.54 Million | 8.46 Million | 8.61 Million | 8.46 Million | 8.72 Million | 8.77 Million |
| Gross Margin | 0.29 | 0.25 | 0.24 | 0.25 | 0.24 | 0.26 |
| EBIT Margin | 0.12 | 0.02 | - | 0.08 | 0.04 | 0.05 |
| Profit Margin | 0.04 | 0.01 | 0.02 | 0.03 | 0.02 | 0.04 |
| EBITDA | 1.72 Billion | 213 Million | - | 1.3 Billion | 507 Million | 644 Million |
| Earnings Before Tax Margin | 0.08 | 0.01 | 0.04 | 0.05 | 0.04 | 0.04 |
CDBDF
UPPR
TANA
MPZZF
000760
300636